CVE-2017-1520

CVE-2017-1520 is a low-severity vulnerability in Ibm Db2 with a CVSS 3.x base score of 3.7. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-287.

Key facts

Description

IBM DB2 9.7, 10,1, 10.5, and 11.1 is vulnerable to an unauthorized command that allows the database to be activated when authentication type is CLIENT. IBM X-Force ID: 129830.

Frequently asked questions

What is CVE-2017-1520?
IBM DB2 9.7, 10,1, 10.5, and 11.1 is vulnerable to an unauthorized command that allows the database to be activated when authentication type is CLIENT. IBM X-Force ID: 129830.
How severe is CVE-2017-1520?
CVE-2017-1520 has a CVSS 3.x base score of 3.7, rated low severity. It is exploitable over network with high attack complexity, requires no privileges and no user interaction. Impact on confidentiality is none, integrity low, and availability none.
Is CVE-2017-1520 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (67th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2017-1520?
CVE-2017-1520 primarily affects Ibm Db2. In total, 56 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2017-1520?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2017-1520 published?
CVE-2017-1520 was published on 2017-09-12 and last updated on 2026-06-17.

References

Affected products (56)

More vulnerabilities in Ibm Db2

All CVEs affecting Ibm Db2 →

Other CWE-287 (Improper Authentication) vulnerabilities

Browse all CWE-287 (Improper Authentication) vulnerabilities →